Clinical Study Confirms Ability to Identify Lung Congestion with Medical-Grade Accuracy TEL AVIV, Israel and WASHINGTON, D.C. – April 4, 2022 – Donisi Health, a MedTech company working to disrupt the readmission cycle of congestive heart failure (CHF) patients, announced results of a clinical study demonstrating the efficacy of its […]
Tag: CHF
The Portability of Aquadex SmartFlow® from CHF Solutions Could Mean More Critically-Ill Patients Have Access to Life-Saving Ultrafiltration Therapy
New Clinical Abstract Available Online During National Kidney Foundation Spring Clinical Meeting (NKF) EDEN PRAIRIE, Minn., April 08, 2021 (GLOBE NEWSWIRE) — Bringing transportable care directly to patients who are too critically-ill to be moved could be the difference between life and death. New evidence demonstrates that ultrafiltration therapy (aquapheresis) […]
CHF Solutions’ Physician-Led Webinar Highlights Real-World Evidence Supporting Effectiveness of Ultrafiltration in Heart Failure Patients
EDEN PRAIRIE, Minn., Jan. 28, 2021 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced key takeaways from its physician-led webinar discussing real-world experience using ultrafiltration (UF) in the management of heart failure patients. Panelists […]
Vida Health Launches Virtual Congestive Heart Failure Management Program
The new program will launch for members from Vida’s national payer customers in December of this year with a full rollout in January of 2021 SAN FRANCISCO–(BUSINESS WIRE)–Expanding on its commitment to improve health outcomes for millions of lives, Vida Health announced a new app-based, coach-centered virtual congestive heart failure (CHF) management […]
CHF Solutions Announces Deployment of Aquadex Systems to Hospitals in the Southeast to Treat COVID-19 Patients
EDEN PRAIRIE, Minn., Oct. 27, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to changing the lives of patients suffering from fluid overload, today announced that it has shipped Aquadex™ product to medical facilities in Tennessee and South Carolina to treat critically ill patients suffering […]
CHF Solutions’ Aquadex Products Granted Federal Supply Schedule Contract
EDEN PRAIRIE, Minn., Aug. 18, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a medical device company dedicated to improving the lives of patients suffering from fluid overload, today announced that its Aquadex™ product line has been added to the Federal Supply Schedule, expanding access to all federal government agencies, […]
CHF Solutions Receives $1.66 Million under SBA’s Paycheck Protection Program and $1.1 Million from Warrant Exercises
EDEN PRAIRIE, Minn., April 21, 2020 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), a small and growing medical device company dedicated to changing the lives of patients suffering from fluid overload, announced receipt of $1.66 million under the Paycheck Protection Program (PPP) under the federal Coronavirus Aid, Relief, and Economic […]
Hackensack Meridian Hackensack University Medical Center First Hospital in Nation to Implant World’s First Heart Failure Neuromodulation Device
BAROSTIM NEO™ provides effective treatment for heart failure patients HACKENSACK, N.J., Feb. 3, 2020 /PRNewswire/ — Hackensack Meridian Hackensack University Medical Center announced today that it is the first hospital in the nation to successfully implant the world’s first heart failure neuromodulation device, BAROSTIM NEO™. This innovative technology is an effective alternative for […]
CHF Solutions Announces Launch of Ultrafiltration Therapy Using Aquadex FlexFlow® System at Beebe Healthcare
EDEN PRAIRIE, Minn., May 15, 2019 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS) today announces that Sussex County, Delaware-based health system, Beebe Healthcare, has initiated offering ultrafiltration therapy using the company’s Aquadex FlexFlow system. “As heart failure and other conditions that contribute to fluid overload expand worldwide, CHF continues to […]
CHF Solutions to Sponsor CT Theatre Session, “Personalized Medicine: Improving Clinical Outcomes with Novel Fluid Management Strategies” Moderated by Renowned Cardiothoracic Surgeon Daniel Beckles, M.D., Ph.D., at the 2019 AATS Annual Meeting
Email Print Friendly Share April 23, 2019 08:30 ET | Source: CHF Solutions, Inc. EDEN PRAIRIE, Minn., April 23, 2019 (GLOBE NEWSWIRE) — CHF Solutions (Nasdaq: CHFS), today announced it will be sponsoring a CT Theatre Session at the American Association for Thoracic Surgery Annual Meeting on Monday, May 6, 2019, 1:00-1:30 pm at the […]